Investigational drugs for treating major depressive disorder

  title={Investigational drugs for treating major depressive disorder},
  author={A. Dhir},
  journal={Expert Opinion on Investigational Drugs},
  pages={24 - 9}
  • A. Dhir
  • Published 2017
  • Medicine
  • Expert Opinion on Investigational Drugs
  • ABSTRACT Introduction: Treatment of patients suffering from major depression could be highly challenging for psychiatrists. Intractability as well as relapse is commonly seen among these patients, leading to functional impairment and poor quality of life. The present review discusses some of the novel investigational drugs that are under pre-clinical or clinical phases in the treatment of major depression. Areas covered: Molecules belonging to different classes such as triple reuptake… CONTINUE READING
    14 Citations
    The use of antidepressants in oncology: a review and practical tips for oncologists
    • 20
    Bipolar depression: a major unsolved challenge
    • 17
    Preclinical Models for Assessment of Antidepressant Abuse Potential
    • 1
    Sub-Acute Oral Toxicity of a Novel Derivative of Agomelatine in Rats in a Sex-Dependent Manner
    • 2
    • PDF


    Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
    • 51
    • PDF
    Major Depressive Disorder and Kappa Opioid Receptor Antagonists
    • 23
    • Highly Influential
    • PDF
    Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
    • 120
    • PDF
    Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5
    • 27
    Glutamate-Based Drug Discovery for Novel Antidepressants
    • 14
    Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
    • M. Pompili, G. Serafini, +5 authors P. Girardi
    • Psychology, Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2013
    • 48
    Ketamine and other glutamate receptor modulators for depression in adults.
    • 115
    The Kappa Opioid Receptor: From Addiction to Depression, and Back
    • 114
    • PDF
    Ketamine followed by memantine for the treatment of major depression.
    • 7
    Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
    • 61
    • Highly Influential
    • PDF